Literature DB >> 7043069

[The Crithidia luciliae immunofluorescence test for detection of antibodies to double-stranded DNA (author's transl)].

P Herzer, G Greif, E M Lemmel.   

Abstract

For measurement of antibodies of double-stranded DNA (ds DNA) the Crithidia luciliae immunofluorescence test (C1-IFT) was compared with the Farr precipitation technique in diagnosis and management of systemic lupus erythematosus (SLE). The C1-IFT proved to be less sensitive in SLE patients without clinical disease activity, but the sensitivity of the test in those with active disease was comparable to that of the Farr test. In 76.9% of the patients' sera identical test results were obtained by both assays. In some sera antibodies were detected only by the C1-IFT. Positive test results in patients with diseases other than SLE were found more often with the Farr test. Thus, The C1-IFT seemed to be more specific for diagnosis of SLE. Measurement of titers using the C1-IFT provides a simple method to survey SL E disease activity. It allows to analyze the immunoglobulin classes of the reacting antibodies and their complement fixation ability in vitro. All three major immunoglobulin classes (IgG, IgM, IgA) were found to be present in the sera with high antibody titers, complement fixation in the C1-IFT could predominantly be detected is sera with high antibody titers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7043069     DOI: 10.1007/bf01711278

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  37 in total

1.  SIGNIFICANCE OF ANTIBODY TO DNA IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  S P CASALS; G J FRIOU; L L MYERS
Journal:  Arthritis Rheum       Date:  1964-08

2.  Isotopes incorporated in the nucleic acids of Trypanosoma mega.

Authors:  G J BONE; M STEINERT
Journal:  Nature       Date:  1956-08-11       Impact factor: 49.962

Review 3.  [The clinical significance of antibodies against double stranded DNA. Comparative study, using the Farr assay and the crithidia luciliae immunofluorescent test (author's transl)].

Authors:  E Genth; W Hagemann; J Sennekamp; W Hartl
Journal:  Immun Infekt       Date:  1977-12

4.  Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors:  P H Schur; J Sandson
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

5.  [The absence of histone in the kinetonucleus of trypanosomes. Cytochemical study].

Authors:  M Steinert
Journal:  Exp Cell Res       Date:  1965-08       Impact factor: 3.905

6.  Clinical significance of antibodies to native DNA as measured by a DNA binding technique in patients with articular features of rheumatoid arthritis.

Authors:  D M Grennan; D Sloane; A Behan; W C Dick
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

7.  Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus.

Authors:  J Holian; I D Griffiths; D N Glass; R N Maini; J T Scott
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

8.  Anti-native DNA detection by the Crithidia luciliae method: an improved guide to the diagnosis and clinical management of systemic lupus erythematosus.

Authors:  S P Ballou; I Kushner
Journal:  Arthritis Rheum       Date:  1979-04

9.  Avidity of antibodies in SLE: relation to severity of renal involvement.

Authors:  S A Leon; A Green; G E Ehrlich; M Poland; B Shapiro
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  1 in total

1.  Antibodies to dsDNA in connective tissue diseases measured by ultramicro enzyme-linked immunosorbent assay (ELISA) adapted to the chamber analytical technique (CAT).

Authors:  U Wollina
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.